Загрузка...
Innegligible musculoskeletal disorders caused by zoledronic acid in adjuvant breast cancer treatment: a meta-analysis
BACKGROUND: Zoledronic acid (ZOL) is widely used for preventing bone loss in early breast cancer patients. However, the adverse effects caused by ZOL itself should not be neglected. Musculoskeletal disorders were common after ZOL administration and distressing to the patients. Up to now, no precise...
Сохранить в:
| Главные авторы: | , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
BioMed Central
2011
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3159097/ https://ncbi.nlm.nih.gov/pubmed/21816036 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1756-9966-30-72 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|